Z-1492-2023 Class I Ongoing

Recalled by Cordis US Corp — Miami Lakes, FL

FDA device recall Z-1492-2023 was initiated by Cordis US Corp on Mar 24, 2023 and is designated Class I. Reason for recall: There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unplanned percutaneous… The recall status is ongoing. Affected quantity: 1058 units.

Recall details

Product Type
Devices
Report Date
May 17, 2023
Initiation Date
Mar 24, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1058 units

Product description

ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 601814RE

Reason for recall

There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unplanned percutaneous or surgical intervention, or stroke; while a replacement device is prepared.

Distribution pattern

Worldwide distribution.

Code information

UDI/DI 20705032056714; Lot Numbers: 35264218, 35264224, 35264806, 35265342, 35265343, 35265382, 35265383, 35265646, 35265656, 35265658, 35264206, 35265645, 35265653

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1492-2023
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1492-2023. Report a data issue: hello@regdatalab.com.